ACBTSA to Discuss Recommendations for Solid Organ Donors and Transplant Recipients for HIV, HBV and HCV at December Meeting

November 16, 2021

The Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will meet Dec. 1 to discuss and vote on a recommendation pertaining to a proposed update to the 2020 public health service guideline for assessing solid organ donors and monitoring transplant recipients for HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) infection.

The Committee will vote on whether the available data support exempting solid organ transplant candidates who are 10 years of age or younger at the time of transplant (and who have received postnatal infectious disease testing) from the recommendation for HIV, HBV and HCV testing during the hospital admission for transplant but prior to anastomosis of the first organ.

The Department of Health and Human Services will publish agenda items for the meeting on the ACBTSA web page when this information becomes available. The public will have an opportunity to present their views to the ACBTSA by submitting a written public comment. Individuals who wish to provide written public comment should review instructions online and respond by midnight on Nov. 26.